drugset / Trial / NCT06849791

A Study to Assess the Relative Bioavailability of Oral ABBV-932 in Healthy Adult Participants

NCT06849791 ↗

Phase 1 Completed 9 enrolled AbbVie
RandomizedCrossoverOpen-labelBasic science

Summary

This study will assess the relative bioavailability and effect of food on pharmacokinetics of ABBV-932 oral administration in healthy adult participants.

Timeline

Start
2025-02-26
Primary completion
2026-05-08
Completion
2026-05-08

Drugs

EvaluationDrugModalityDoseRoute
Subject ABBV-932 Unknown — Oral

Indications

No indication recorded.